PF-06671008 Dose Escalation Study in Advanced Solid Tumors
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Neoplasms
Interventions: DRUG: PF-06671008|DRUG: PF-06671008
Sponsor: Pfizer